NEWS6 April 2017

Gallant named CEO of Cello Health Insight US

Healthcare News North America People

US – Cello Health Insight has announced a reorganisation of its US senior team, including the appointment of Kathryn Gallant as CEO.  

Kathryn_Gallant crop

Gallant (pictured) will take on overall responsibility for the growth of Cello Health Insight across the US, as well as building the US international revenue stream. 

Meanwhile Angie Wheeler has been made president and, in addition to leading the Chicago office, she will take overall responsibility for building Cello Health Insight’s US domestic market business. 

A number of new hires have also been announced: Justine Trinidad joins as the newest US director of IQ, Cello Health Insight’s specialist quantitative research practice; Ed Geiselhart joins as a Chicago-based director; and Kaity Arctander joins as a senior account manager. 

“Kathryn and Angie have worked in partnership with great success for many years to build Cello Health Insight, US,"  said Jane Shirley, CEO of Cello Health Insight.

"This development in their roles combined with the new additions opens up further leadership opportunities for the team and truly supports our ability to drive growth and expand the business.”